Jacobs Levy Equity Management Inc. Buys 81,516 Shares of Arteris, Inc. $AIP

Key Points

• Jacobs Levy Equity Management Inc. increased its stake in Arteris, Inc. by 48.5%, acquiring an additional 81,516 shares, resulting in a total ownership of approximately 0.60% of the company valued at $1.72 million.
• Several hedge funds have significantly altered their positions in Arteris, with CWM LLC increasing its stake by an impressive 4,810.1%.
• Equities analysts are largely optimistic, with three analysts giving Arteris a Buy rating and a consensus target price of $15.00, despite some recent downgrades.

Jacobs Levy Equity Management Inc. lifted its stake in Arteris, Inc. (NASDAQ:AIP - Free Report) by 48.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 249,517 shares of the company's stock after buying an additional 81,516 shares during the period. Jacobs Levy Equity Management Inc. owned about 0.60% of Arteris worth $1,724,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Next Century Growth Investors LLC raised its holdings in shares of Arteris by 46.4% in the 1st quarter. Next Century Growth Investors LLC now owns 407,721 shares of the company's stock worth $2,817,000 after buying an additional 129,143 shares in the last quarter. Federated Hermes Inc. raised its holdings in shares of Arteris by 97.2% in the 1st quarter. Federated Hermes Inc. now owns 327,119 shares of the company's stock worth $2,260,000 after buying an additional 161,241 shares in the last quarter. Roubaix Capital LLC raised its holdings in shares of Arteris by 33.2% in the 1st quarter. Roubaix Capital LLC now owns 281,450 shares of the company's stock worth $1,945,000 after buying an additional 70,111 shares in the last quarter. Trexquant Investment LP grew its position in Arteris by 22.9% during the 1st quarter. Trexquant Investment LP now owns 247,041 shares of the company's stock worth $1,707,000 after acquiring an additional 46,094 shares during the last quarter. Finally, Millennium Management LLC grew its position in Arteris by 56.5% during the 4th quarter. Millennium Management LLC now owns 238,309 shares of the company's stock worth $2,428,000 after acquiring an additional 85,996 shares during the last quarter. 64.36% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. TD Cowen increased their price target on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Wall Street Zen lowered Arteris from a "hold" rating to a "sell" rating in a research report on Sunday, September 7th. Finally, Rosenblatt Securities restated a "buy" rating and set a $14.00 price target on shares of Arteris in a research report on Wednesday, May 21st. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has an average rating of "Buy" and an average price target of $15.00.

Arteris Price Performance

Shares of AIP stock traded down $0.18 on Friday, reaching $8.75. 352,580 shares of the stock were exchanged, compared to its average volume of 515,290. Arteris, Inc. has a one year low of $5.46 and a one year high of $14.29. The stock has a market cap of $373.19 million, a PE ratio of -10.67 and a beta of 1.44. The stock has a 50 day moving average price of $9.48 and a 200 day moving average price of $8.21.

Arteris (NASDAQ:AIP - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, hitting analysts' consensus estimates of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The firm had revenue of $16.50 million during the quarter, compared to analyst estimates of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, research analysts expect that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Insider Buying and Selling at Arteris

In other news, COO Laurent R. Moll sold 42,692 shares of the firm's stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $8.94, for a total value of $381,666.48. Following the transaction, the chief operating officer directly owned 399,379 shares in the company, valued at $3,570,448.26. This trade represents a 9.66% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Bayview Legacy, Llc sold 50,000 shares of the company's stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $13.12, for a total value of $656,000.00. Following the completion of the sale, the insider owned 9,839,071 shares of the company's stock, valued at $129,088,611.52. This represents a 0.51% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 510,616 shares of company stock valued at $5,979,663. 29.10% of the stock is currently owned by corporate insiders.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.